Clinical trial
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
NCT07673822 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 8, 2026
- Completion date
- August 3, 2026
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk, chronic kidney disease, diabetes mellitus, type 2, obesity